The global reinsurers’ outlook promising but uncertain. The global reinsurance market is expected to grow modestly, with the most substantial growth predicted for the Asia-Pacific and Latin America regions, according to Munich Re. The market for alternative risk transfer adjusted for higher equity effects from interest rates is also expected to rebound to $461bn in 2023 from $434bn in 2022. Investing in risk modeling and high-definition models, as well as harnessing data and technology are priorities.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
